Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Public ClinicalTrials.gov record NCT02175225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The investigators hypothesize that treatment with the iron chelator, Deferoxamine Mesylate, improves the outcome of patients with brain hemorrhage. The purpose of this study is to determine whether treatment with Deferoxamine Mesylate is of sufficient promise to improve outcome before pursuing a larger clinical trial to examine its effectiveness as a treatment for intracerebral hemorrhage.
Study identification
- NCT ID
- NCT02175225
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 294 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2014 (Actual)
- Primary completion
- Feb 10, 2018 (Actual)
- Completion
- May 30, 2018 (Actual)
- Last update posted
- May 30, 2019
2014 – 2018
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital / Barrow Neurological Institute | Phoenix | Arizona | — | — |
| Stanford University Medical Center | Palo Alto | California | — | — |
| San Francisco General Hospital | San Francisco | California | — | — |
| Yale New Haven Hospital | New Haven | Connecticut | — | — |
| University of Florida | Jacksonville | Florida | — | — |
| Loyola University Medical Center | Chicago | Illinois | — | — |
| RUSH University Medical Center | Chicago | Illinois | — | — |
| University of Iowa Medical Center | Iowa City | Iowa | — | — |
| Johns Hopkins Hospital | Baltimore | Maryland | — | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | — | — |
| UMass Memorial Medical Center | Worcester | Massachusetts | — | — |
| Henry Ford Hospital | Detroit | Michigan | — | — |
| Columbia University | New York | New York | — | — |
| Mount Sinai Hospital | New York | New York | — | — |
| NYU Langone Medical Center | New York | New York | — | — |
| Weill Medical College of Cornell University | New York | New York | — | — |
| University of North Carolina Medical Center | Chapel Hill | North Carolina | — | — |
| Duke University Medical Center | Durham | North Carolina | — | — |
| University Hospital Case Medical Center | Cleveland | Ohio | — | — |
| The Ohio State University Medical Center | Columbus | Ohio | — | — |
| Oregon Health & Science University Medical Center | Portland | Oregon | — | — |
| University of Pennsylvania Medical Center | Philadelphia | Pennsylvania | — | — |
| Rhode Island Hospital | Providence | Rhode Island | — | — |
| Medical University of South Carolina | Charleston | South Carolina | — | — |
| University of Texas Health Sciences Center | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02175225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2019 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02175225 live on ClinicalTrials.gov.